Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance By: CNBC.com News May 07, 2024 at 11:33 AM EDT Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance By: CNBC.com News May 07, 2024 at 11:33 AM EDT Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments. Read More >>